Do cross-registry comparisons of black and white americans provide support for N-Acetylation as an important determinant for urinary bladder and other tobacco-related cancers?

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 2, 2006, Pages 267-273

  Moore, Malcolm A ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Ethnic variation; Larynx; Lung; Pancreas; Smoking associated cancers; Urinary bladder

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

AFRICAN AMERICAN; ARTICLE; CANCER REGISTRY; CAUCASIAN; CLUSTER ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; NEOPLASM; PHYSIOLOGY; SMOKING; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; ARYLAMINE N-ACETYLTRANSFERASE; CLUSTER ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; SEER PROGRAM; SMOKING; UNITED STATES;

EID: 33748471573     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Agundez JA, Ladero JM, Olivera M, Abildua R, Roman JM, Benitez J. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology. 1995 Jan-Feb;52(1):7-11.
2. Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 2004;28(3):187-93.
3. Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS. Statespecific prevalence of selected chronic disease-related characteristics-Behavioral Risk Factor Surveillance System, 2001. MMWR Surveill Summ. 2003 Aug 22;52(8):1-80.
4. Badawi AF, Stern SJ, Lang NP, Kadlubar FF. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. Prog Clin Biol Res. 1996;395:109-40.
5. Bitterman WA, Farhadian H, Abu S-C, et al (1991). Environmental and nutritional factors significantly associated with cancer of the urinary tract among different ethnic groups. Urologic Clin North Am, 18, 501-8.
6. Brooks DR, Palmer JR, Strom BL, Rosenberg L. Menthol cigarettes and risk of lung cancer. Am J Epidemiol. 2003 O158(7):609-16; discussion 617-20.
7. Burns PB, Swanson GM. Risk of urinary bladder cancer among blacks and whites: the role of cigarette use and occupation. Cancer Causes Control. 1991 Nov;2(6):371-9.
8. Cantor KP. Hoover R. Hartge P, et al (1987). Bladder cancer, drinking water source, and tap water consumption: a casecontrol study. J Natl Cancer Inst, 79, 1269-79.
9. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL, Maurer KR. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998 Jul 8;280(2):135-9.
10. Chan KW, Wong KY, Srivastava G. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 1997;50:1018-21.
11. Chang-Claude J, Kropp S, Jager B, Bartsch H, Risch A. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):698-704.
12. Chen C, Ricks S, Doody DR, Fitzgibbons ED, Porter PL, Schwartz SM. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis. 2001 Dec;22(12):1993-9.
13. Chun TY. Coincidence of bladder and prostate cancer. J Urol. 1997 Jan;157(1):65-7.
14. Cohen SM, Shirai T, Steineck G. Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl. 2000;(205):105-15.
15. Costa S, Medeiros R, Vasconcelos A, Pinto D, Lopes C. A slow acetylator genotype associated with an increased risk of advanced cervical cancer. J Cancer Res Clin Oncol. 2002 Dec;128(12):678-82.
16. Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Race. visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1932-8.
17. Dewan A, Chattopadhyay P, Kulkarni PK. N-acetyltransferase activity-a susceptibility factor in human bladder carcinogenesis. Indian J Cancer. 1995 Mar;32(1):15-9.
18. Drozdz M, Gierek T, Jendryczko A, Pilch J, Piekarska J. Nacetyltransferase phenotype of patients with cancer of the larynx. Neoplasma. 1987;34(4):481-4.
19. Farker K, Schotte U, Scheele J, Hoffmann A. Impact of Nacetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)-an investigation in a department of surgical medicine. Exp Toxicol Pathol. 2003 Jun;54(5-6):387-91.
20. Fukutome K, Watanabe M, Shiraishi T, Murata M, Uemura H, Kubota Y, Kawamura J, Ito H, Yatani R. N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development. Cancer Lett. 1999 Feb 8;136(1):83-7.
21. Gao JP, Huang YD, Lin JA, Zhu QC, Liang JP. [Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma] Zhonghua Gan Zang Bing Za Zhi. 2003 Jan;11(1):20-2. [Article in Chinese]
22. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002 94(6):1867-75.
23. Hahn M, Hagedorn G, Kuhlisch E, Schackert HK, Eckelt U. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol. 2002 Jul;38(5):486-90.
24. Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int J Urol. 2003 Mar;10(3):167-73.
25. Hanssen HP, Agarwal DP, Goedde HW, Bucher H, Huland H, Brachmann W, Ovenbeck R. Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population. Eur Urol. 1985;11(4):263-6.
26. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta. 1988 Aug 3;948(1):37-66.
27. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42.
28. Hein DW, Leff MA, Ishibe N, Sinha R, Frazier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ Mol Mutagen. 2002;40(3):161-7.
29. Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer. 1999 81(3):537-41.
30. Huang CS, Chern HD, Shen CY, Hsu SM, Chang KJ. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer. 1999 82(2):175-9.
31. Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol. 2003 98(6):1417-22.
32. Hubbard AL, Harrison DJ, Moyes C, Wyllie AH, Cunningham C, Mannion E, Smith CA. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut. 1997 Aug;41(2):229-34.
33. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer. 2004 110(4):598-604.
34. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans. (1986) Vol. 37. Tobacco Smoking. IARC, Lyon.
35. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Nacetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Int J Toxicol. 2004 Jan-Feb;23(1):25-31.
36. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004 Apr;99(4):582-8.
37. Ladero JM, Agundez JA, Olivera M, Lozano L, Rodriguez-Lescure A, Diaz-Rubio M, Benitez J. N-acetyltransferase 2 singlenucleotide polymorphisms and risk of gastric carcinoma. Eur J Clin Pharmacol. 2002 May;58(2):115-8.
38. Lei D, Pan X, Guo C, Xu F, Zhang L, Liu D, Luan X. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma] Zhonghua Zhong Liu Za Zhi. 2002 Mar;24(2):154-6.
39. Lin HJ, Han CY, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics. 1994 Jun;4(3):125-34.
40. Loktionov A, Moore W, Spencer SP, Vorster H, Nell T, O'Neill IK, Bingham SA, Cummings JH. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention. Cancer Detect Prev. 2002;26(1):15-22.
41. Lu CM, Lan SJ, Lee YH, et al (1999). Tea consumption fluid intake and bladder cancer risk in Southern Taiwan. Urology, 54, 823-8.
42. Martinez C, Agundez JA, Olivera M, Martin R, Ladero JM, Benitez J. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics. 1995 Aug;5(4):207-14.
43. Moore, MA (2000). Awash with alcohol in the world of prevention. Asian Pac J Cancer Prev. 1,91-93.
44. Moore MA, Tajima, K (2004). We are what we eat - but what do we eat? A role for coordination of cancer ristration and dietary intake? Asian Pac J Cancer Prev. 5,229-230.
45. Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H, Monden M. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer. 1999 Mar 1;80(5):685-8.
46. Morita S, Yano M, Tsujinaka T, Ogawa A, Taniguchi M, Kaneko K, Shiozaki H, Doki Y, Inoue M, Monden M. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamouscell carcinoma of the esophagus. Int J Cancer. 1998 Oct 23;79(5):517-20.
47. Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev. 2001 Feb;10(1):7-14.
48. Nguyen AM, Luke CG, Roder D. Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pacific J Cancer Prev 2003;4:225-31.
49. Okosun IS, Boltri JM, Anochie LK, Chandra KM. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risks of abdominal obesity. J Hum Hypertens. 2004 Dec;18(12):849-55.
50. Oyama T, Kawamoto T, Mizoue T, Yasumoto K, Kodama Y, Mitsudomi T. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res. 1997 Jan-Feb;17(1B):577-81.
51. Pashos CL, Botteman MF, Laskin BL, Redaelli A. Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 2002 Nov-Dec;10(6):311-22.
52. Pawlik WW, Jacobson ED, Banks RO. Actions of nicotine on renal function in dogs. Proc Soc Exp Biol Med. 1985 Apr;178(4):585-90.
53. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998 Jul 8;280(2):152-6.
54. Philip PA, Fitzgerald DL, Cartwright RA, Peake MD, Rogers HJ. Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis. 1988 Mar;9(3):491-3.
55. Probert JL, Persad RA, Greenwood RP, Gillatt DA, Smith PJ. Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England. Br J Urol. 1998 Nov;82(5):660-6.
56. Richardson TL. African-American smokers and cancers of the lung and of the upper respiratory and digestive tracts. Is menthol part of the puzzle? West J Med. 1997 Mar;166(3):189-94.
57. Richie JP Jr, Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobaccospecific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):783-90.
58. Rodriguez JW, Kirlin WG, Ferguson RJ, Doll MA, Gray K, Rustan TD, Lee ME, Kemp K, Urso P, Hein DW. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch Toxicol. 1993;67(7):445-52.
59. Schulz MR, Loomis D. Occupational bladder cancer mortality among racial and ethnic minorities in 21 states. Am J Ind Med. 2000 Jul;38(1):90-8.
60. Shibuta J, Eto T, Kataoka A, Inoue H, Ueo H, Suzuki T, Barnard GF, Mori M. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. Am J Gastroenterol. 2001 Dec;96(12):3419-24.
61. Stellman SD, Chen Y, Muscat JE, Djordjevic MV, Richie JP Jr, Lazarus P, Thompson S, Altorki N, Berwick M, Citron ML, Harlap S, Kaur TB, Neugut AI, Olson S, Travaline JM, Witorsch P, Zhang ZF. Lung cancer risk in white and black Americans. Ann Epidemiol. 2003 Apr;13(4):294-302.
62. Summerson JH, Bell RA, Konen JC. Coronary heart disease risk factors in black and white patients with non-insulin-dependent diabetes mellitus. Ethn Health. 1996 Mar;1(1):9-20.
63. Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y, Katoh T. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol. 2004 Feb;130(2):99-106.
64. Varzim G, Monteiro E, Silva R, Pinheiro C, Lopes C. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility. ORL J Otorhinolaryngol Relat Spec. 2002 May-Jun;64(3):206-12.
65. Wang CY, Jones RF, Debiec-Rychter M, Soos G, Haas GP. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study. Anticancer Res. 2002 Nov-Dec;22(6B):3529-35.
66. Wilkens LR, Kadir MM, Kolonel LN, Nomura AM, Hankin JH (1996). Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosamines, and selected foods. Cancer Epidemiol Bioimarkers Prev, 5, 161-6.
67. World Cancer Research Fund/American Institute for Cancer Research (1997). Food, Nutrition and the Prevention of Cancer
68. Wu, A.H., Tseng, C.C., Bernstein, L., Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric, adenocarcinoma., Cancer. 2003 Sep 1;98(5):940-8.
69. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst. 1994 May 4;86(9):712-6.
70. Yun AJ, Bazar KA, Lee PY, Gerber A, Daniel SM. The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine. Med Hypotheses. 2005;64(6):1073-9.
71. Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Genetic polymorphisms in Nacetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):15-21.
72. Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer 2003;105:681-6.
73. Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol. 1998 Jan;14(1):9-21.